{
    "id": 19975,
    "fullName": "ANGPT2 wild-type",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "Wild-type ANGPT2 indicates that no mutation has been detected within the ANGPT2 gene.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 285,
        "geneSymbol": "ANGPT2",
        "terms": [
            "ANGPT2",
            "AGPT2",
            "ANG2"
        ]
    },
    "variant": "wild-type",
    "createDate": "03/21/2016",
    "updateDate": "01/02/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 5252,
            "approvalStatus": "Phase I",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase I trial, Nesvacumab demonstrated safety and preliminary efficacy in patients with advanced solid tumors, resulting in stable disease in 4% (2/47) of patients (PMID: 26490310).",
            "molecularProfile": {
                "id": 20412,
                "profileName": "ANGPT2 wild-type"
            },
            "therapy": {
                "id": 3799,
                "therapyName": "Nesvacumab",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 4962,
                    "pubMedId": 26490310,
                    "title": "A Phase I First-in-Human Study of Nesvacumab (REGN910), a Fully Human Anti-Angiopoietin-2 (Ang2) Monoclonal Antibody, in Patients with Advanced Solid Tumors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26490310"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 20412,
            "profileName": "ANGPT2 wild-type",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}